Collaboration for sustainable growth in the fourth industrial revolution

The Foundation for collaboration between the universities of Uppsala, business and society – STUNS was initiated in 1983 and has conducted operations in the Uppsala region since 1985. STUNS’s purpose is to develop the collaboration between the universities of Uppsala, the businesses, and public organizations. Life science has a strong position in the Uppsala region with leading research at both universities, a business community consisting of large and medium-sized established and exporting companies, and a large number of innovative, smaller companies. In addition, the University Hospital and the University Animal Hospital at SLU offer competent user environments.

Collaboration for sustainable growth in the fourth industrial revolution

The Foundation for collaboration between the universities of Uppsala, business and society – STUNS was initiated in 1983 and has conducted operations in the Uppsala region since 1985. STUNS’s purpose is to develop the collaboration between the universities of Uppsala, the businesses, and public organizations. Life science has a strong position in the Uppsala region with leading research at both universities, a business community consisting of large and medium-sized established and exporting companies, and a large number of innovative, smaller companies. In addition, the University Hospital and the University Animal Hospital at SLU offer competent user environments.

The region of Uppsala (Sweden) is the intermediate region with the highest overall position – sixth place– just ahead of one of the urban regions. The presence of a large university and life science sector helps to explain why Uppsala has the highest proportion of people with tertiary education and the highest level of R&D investment per capita of the intermediate regions. The region also benefits from the proximity of the capital region of Stockholm and Arlanda Airport, which contributes to Uppsala’s high net migration rate.

of total Swedish Life science revenue with only

of the total Swedish population